Faculty who have authored publication Phase 1, open-label, dose-escalation, and pharmacokinetic study of STAT3 inhibitor OPB-31121 in subjects with advanced solid tumors.
Name | Title | Department | Institution |
---|---|---|---|
Razelle Kurzrock MD | Center Associate Director, Professor | Medicine | Medical College of Wisconsin |